Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
Benzinga 在 2023 年 6 月 22 日的最高评级上调、下调
Upgrades
升级
For DiaMedica Therapeutics Inc (NASDAQ:DMAC), Oppenheimer upgraded the previous rating of Perform to Outperform. In the first quarter, DiaMedica Therapeutics showed an EPS of $0.20, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.05 and a 52-week-low of $1.12. DiaMedica Therapeutics closed at $3.64 at the end of the last trading period.
对于 Diamedica Therapeut （纳斯达克股票代码：DMAC），奥本海默将之前的业绩评级上调至跑赢大盘。在第一季度，Diamedica Therapeutics的每股收益为0.20美元，而去年同期为0.13美元。目前，该股创下52周高点4.05美元，创52周低点1.12美元。Diamedica Therapeutics在上一个交易期末收于3.64美元。
For Kellogg Co (NYSE:K), Bernstein upgraded the previous rating of Underperform to Market Perform. For the first quarter, Kellogg had an EPS of $1.10, compared to year-ago quarter EPS of $1.10. At the moment, the stock has a 52-week-high...
对于 凯洛格公司 （纽约证券交易所代码：K），伯恩斯坦将先前的表现不佳评级上调至...
登录免费看全文
登录/注册